Suppr超能文献

比较口服右美托咪定与口服咪达唑仑作为小儿七氟醚麻醉后预防苏醒期躁动的术前用药。

Comparison of oral dexmedetomidine versus oral midazolam as premedication to prevent emergence agitation after sevoflurane anaesthesia in paediatric patients.

作者信息

Prabhu M Kavya, Mehandale Sripada G

机构信息

Department of Anaesthesiology and Critical Care, K. S. Hegde Medical Academy, Nitte University, Mangaluru, Karnataka, India.

出版信息

Indian J Anaesth. 2017 Feb;61(2):131-136. doi: 10.4103/0019-5049.199852.

Abstract

BACKGROUND AND AIMS

Sevoflurane is the most often used inhalational agent in paediatric anaesthesia, but emergence agitation (EA) remains a major concern. Oral midazolam and parenteral dexmedetomidine are known to be effective in controlling EA. We attempted to elucidate whether oral dexmedetomidine is better than midazolam in controlling EA.

METHODS

Prospective double-blinded study involving ninety patients aged 1-10 years, undergoing elective surgeries of <2 h of expected duration under sevoflurane general anaesthesia, randomised to receive either midazolam (Group A) or dexmedetomidine (Group B) as oral premedication was carried out to record level of sedation before induction, haemodynamic parameters and recovery time. Incidence and severity of EA, post-operative pain and requirement of rescue analgesic were assessed at 0, 5, 15, 30 and 60 min postoperatively.

RESULTS

Data were analysed applying Student's -test and Chi-square test using SPSS software. Mask acceptance was better in Group B (97.8% vs. 73.4%, < 0.001). Mean arterial pressure was lower in Group B ( < 0.001) though clinically not significant. More rescue analgesic was required in Group A (5.6% vs. 0%). There was no significant difference in adverse effects. Although there was a higher incidence of EA in Group A (Aono's score 3 and 4; 40% vs. 4.4%), none of them required intervention (paediatric anaesthesia emergence delirium score >10; 0 vs. 0).

CONCLUSION

Premedication with oral dexmedetomidine provides smooth induction and recovery, reduces the EA and provides better analgesia and sedation as compared to oral midazolam.

摘要

背景与目的

七氟醚是小儿麻醉中最常用的吸入麻醉剂,但苏醒期躁动(EA)仍是一个主要问题。已知口服咪达唑仑和静脉注射右美托咪定可有效控制EA。我们试图阐明口服右美托咪定在控制EA方面是否优于咪达唑仑。

方法

一项前瞻性双盲研究,纳入90例年龄在1至10岁之间、预计在七氟醚全身麻醉下进行时长小于2小时的择期手术患者,随机分为接受咪达唑仑(A组)或右美托咪定(B组)作为口服术前用药,记录诱导前的镇静水平、血流动力学参数和恢复时间。在术后0、5、15、30和60分钟评估EA的发生率和严重程度、术后疼痛及补救性镇痛的需求。

结果

使用SPSS软件应用学生t检验和卡方检验分析数据。B组对药物的接受度更好(97.8%对73.4%,P<0.001)。B组平均动脉压较低(P<0.001),但临床上无显著差异。A组需要更多的补救性镇痛(5.6%对0%)。不良反应方面无显著差异。虽然A组EA的发生率较高(Aono评分3分和4分;40%对4.4%),但均无需干预(小儿麻醉苏醒期谵妄评分>10;0对0)。

结论

与口服咪达唑仑相比,口服右美托咪定进行术前用药可提供平稳的诱导和恢复,减少EA,并提供更好的镇痛和镇静效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fae6/5330069/b14e12a0386c/IJA-61-131-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验